Alzheimer's Disease Market - Global Outlook and Forecast 2023-2028

Report ID: 1091553 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Alzheimer's Disease Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Alzheimer's Disease Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Alzheimer's Disease Overall Market Size
    2.1 Global Alzheimer's Disease Market Size: 2021 VS 2028
    2.2 Global Alzheimer's Disease Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Alzheimer's Disease Players in Global Market
    3.2 Top Global Alzheimer's Disease Companies Ranked by Revenue
    3.3 Global Alzheimer's Disease Revenue by Companies
    3.4 Top 3 and Top 5 Alzheimer's Disease Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Alzheimer's Disease Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Players in Global Market
        3.6.1 List of Global Tier 1 Alzheimer's Disease Companies
        3.6.2 List of Global Tier 2 and Tier 3 Alzheimer's Disease Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Alzheimer's Disease Market Size Markets, 2021 & 2028
        4.1.2 Donepezil
        4.1.3 Memantine
        4.1.4 Rivastigmine
    4.2 By Type - Global Alzheimer's Disease Revenue & Forecasts
        4.2.1 By Type - Global Alzheimer's Disease Revenue, 2017-2022
        4.2.2 By Type - Global Alzheimer's Disease Revenue, 2023-2028
        4.2.3 By Type - Global Alzheimer's Disease Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Alzheimer's Disease Market Size, 2021 & 2028
        5.1.2 Early to Moderate Stages
        5.1.3 Moderate to Severe Stages
    5.2 By Application - Global Alzheimer's Disease Revenue & Forecasts
        5.2.1 By Application - Global Alzheimer's Disease Revenue, 2017-2022
        5.2.2 By Application - Global Alzheimer's Disease Revenue, 2023-2028
        5.2.3 By Application - Global Alzheimer's Disease Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Alzheimer's Disease Market Size, 2021 & 2028
    6.2 By Region - Global Alzheimer's Disease Revenue & Forecasts
        6.2.1 By Region - Global Alzheimer's Disease Revenue, 2017-2022
        6.2.2 By Region - Global Alzheimer's Disease Revenue, 2023-2028
        6.2.3 By Region - Global Alzheimer's Disease Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Alzheimer's Disease Revenue, 2017-2028
        6.3.2 US Alzheimer's Disease Market Size, 2017-2028
        6.3.3 Canada Alzheimer's Disease Market Size, 2017-2028
        6.3.4 Mexico Alzheimer's Disease Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Alzheimer's Disease Revenue, 2017-2028
        6.4.2 Germany Alzheimer's Disease Market Size, 2017-2028
        6.4.3 France Alzheimer's Disease Market Size, 2017-2028
        6.4.4 U.K. Alzheimer's Disease Market Size, 2017-2028
        6.4.5 Italy Alzheimer's Disease Market Size, 2017-2028
        6.4.6 Russia Alzheimer's Disease Market Size, 2017-2028
        6.4.7 Nordic Countries Alzheimer's Disease Market Size, 2017-2028
        6.4.8 Benelux Alzheimer's Disease Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Alzheimer's Disease Revenue, 2017-2028
        6.5.2 China Alzheimer's Disease Market Size, 2017-2028
        6.5.3 Japan Alzheimer's Disease Market Size, 2017-2028
        6.5.4 South Korea Alzheimer's Disease Market Size, 2017-2028
        6.5.5 Southeast Asia Alzheimer's Disease Market Size, 2017-2028
        6.5.6 India Alzheimer's Disease Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Alzheimer's Disease Revenue, 2017-2028
        6.6.2 Brazil Alzheimer's Disease Market Size, 2017-2028
        6.6.3 Argentina Alzheimer's Disease Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Alzheimer's Disease Revenue, 2017-2028
        6.7.2 Turkey Alzheimer's Disease Market Size, 2017-2028
        6.7.3 Israel Alzheimer's Disease Market Size, 2017-2028
        6.7.4 Saudi Arabia Alzheimer's Disease Market Size, 2017-2028
        6.7.5 UAE Alzheimer's Disease Market Size, 2017-2028
7 Players Profiles
    7.1 Allergan
        7.1.1 Allergan Corporate Summary
        7.1.2 Allergan Business Overview
        7.1.3 Allergan Alzheimer's Disease Major Product Offerings
        7.1.4 Allergan Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.1.5 Allergan Key News
    7.2 Eisai
        7.2.1 Eisai Corporate Summary
        7.2.2 Eisai Business Overview
        7.2.3 Eisai Alzheimer's Disease Major Product Offerings
        7.2.4 Eisai Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.2.5 Eisai Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Alzheimer's Disease Major Product Offerings
        7.3.4 Novartis Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Daiichi Sankyo
        7.4.1 Daiichi Sankyo Corporate Summary
        7.4.2 Daiichi Sankyo Business Overview
        7.4.3 Daiichi Sankyo Alzheimer's Disease Major Product Offerings
        7.4.4 Daiichi Sankyo Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.4.5 Daiichi Sankyo Key News
    7.5 Merz Pharma
        7.5.1 Merz Pharma Corporate Summary
        7.5.2 Merz Pharma Business Overview
        7.5.3 Merz Pharma Alzheimer's Disease Major Product Offerings
        7.5.4 Merz Pharma Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.5.5 Merz Pharma Key News
    7.6 Pfizer
        7.6.1 Pfizer Corporate Summary
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Alzheimer's Disease Major Product Offerings
        7.6.4 Pfizer Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.6.5 Pfizer Key News
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Corporate Summary
        7.7.2 Johnson & Johnson Business Overview
        7.7.3 Johnson & Johnson Alzheimer's Disease Major Product Offerings
        7.7.4 Johnson & Johnson Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.7.5 Johnson & Johnson Key News
    7.8 Lundbeck
        7.8.1 Lundbeck Corporate Summary
        7.8.2 Lundbeck Business Overview
        7.8.3 Lundbeck Alzheimer's Disease Major Product Offerings
        7.8.4 Lundbeck Alzheimer's Disease Revenue in Global Market (2017-2022)
        7.8.5 Lundbeck Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Alzheimer's Disease Market Opportunities & Trends in Global Market
    Table 2. Alzheimer's Disease Market Drivers in Global Market
    Table 3. Alzheimer's Disease Market Restraints in Global Market
    Table 4. Key Players of Alzheimer's Disease in Global Market
    Table 5. Top Alzheimer's Disease Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Alzheimer's Disease Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Alzheimer's Disease Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Alzheimer's Disease Product Type
    Table 9. List of Global Tier 1 Alzheimer's Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Alzheimer's Disease Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Alzheimer's Disease Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Alzheimer's Disease Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Alzheimer's Disease Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Alzheimer's Disease Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Alzheimer's Disease Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
    Table 30. Allergan Corporate Summary
    Table 31. Allergan Alzheimer's Disease Product Offerings
    Table 32. Allergan Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 33. Eisai Corporate Summary
    Table 34. Eisai Alzheimer's Disease Product Offerings
    Table 35. Eisai Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Alzheimer's Disease Product Offerings
    Table 38. Novartis Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 39. Daiichi Sankyo Corporate Summary
    Table 40. Daiichi Sankyo Alzheimer's Disease Product Offerings
    Table 41. Daiichi Sankyo Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 42. Merz Pharma Corporate Summary
    Table 43. Merz Pharma Alzheimer's Disease Product Offerings
    Table 44. Merz Pharma Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 45. Pfizer Corporate Summary
    Table 46. Pfizer Alzheimer's Disease Product Offerings
    Table 47. Pfizer Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 48. Johnson & Johnson Corporate Summary
    Table 49. Johnson & Johnson Alzheimer's Disease Product Offerings
    Table 50. Johnson & Johnson Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
    Table 51. Lundbeck Corporate Summary
    Table 52. Lundbeck Alzheimer's Disease Product Offerings
    Table 53. Lundbeck Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Alzheimer's Disease Segment by Type in 2021
    Figure 2. Alzheimer's Disease Segment by Application in 2021
    Figure 3. Global Alzheimer's Disease Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Alzheimer's Disease Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Alzheimer's Disease Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Alzheimer's Disease Revenue in 2021
    Figure 8. By Type - Global Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 12. US Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 16. Germany Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 17. France Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 24. China Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 28. India Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 30. Brazil Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Alzheimer's Disease Revenue Market Share, 2017-2028
    Figure 33. Turkey Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
    Figure 37. Allergan Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Eisai Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Daiichi Sankyo Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Merz Pharma Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Pfizer Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Johnson & Johnson Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Lundbeck Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Frequently Asked Questions
Alzheimer's Disease Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer's Disease Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer's Disease Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports